Black Diamond Therapeutics (BDTX) Institutional Ownership

$1.96 +0.03 (+1.55%)

Closing price 09/18/2026 04:00 PM Eastern

Extended Trading

$1.96 +0.01 (+0.26%)

As of 09/18/2026 07:46 PM Eastern

Compare

Current Institutional Ownership Percentage: 95.47%
Number of Institutional Buyers (last 12 months): 54
Total Institutional Inflows (last 12 months): $31.47M

Number of Institutional Sellers (last 12 months): 17
Total Institutional Outflows (last 12 months): $37.14M

Get BDTX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Black Diamond Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BDTX Institutional Buying and Selling by Quarter

Black Diamond Therapeutics Major Shareholders & Ownership History

Export

Reporting Date	Major Shareholder Name	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
9/8/2026	Spark Investment Management LLC	15,500	$29K	0.1%	N/A	0.027%
8/18/2026	RB Capital Management LLC	100,000	$185K	0.0%	N/A	0.174%
8/18/2026	Empowered Funds LLC	248,134	$459K	0.0%	N/A	0.432%
8/17/2026	Bank of America Corp DE	413,516	$765K	0.0%	N/A	0.720%
8/15/2026	AWM Investment Company Inc.	1,000,000	$1.85M	0.2%	N/A	1.741%
8/14/2026	Hsbc Holdings PLC	26,421	$46K	0.0%	N/A	0.046%
8/14/2026	EFG International AG	27,000	$50K	0.0%	N/A	0.047%
8/14/2026	Canada Pension Plan Investment Board	103,600	$192K	0.0%	N/A	0.180%
8/13/2026	Connor Clark & Lunn Investment Management Ltd.	1,092,885	$2.02M	0.0%	N/A	1.902%
8/7/2026	BlackRock Inc.	3,917,088	$7.25M	0.0%	N/A	6.836%
Get the Latest News and Ratings for BDTX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Black Diamond Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
8/7/2026	Deutsche Bank AG	46,038	$85K	0.0%	N/A	0.080%
8/6/2026	Bank of New York Mellon Corp	318,763	$590K	0.0%	N/A	0.556%
8/6/2026	GSA Capital Partners LLP	220,907	$409K	0.0%	N/A	0.386%
5/19/2026	Bank of America Corp DE	114,143	$243K	0.0%	+123.4%	0.199%
5/18/2026	Empowered Funds LLC	230,177	$490K	0.0%	N/A	0.402%
5/15/2026	OMERS ADMINISTRATION Corp	62,800	$134K	0.0%	-54.8%	0.110%
5/14/2026	Renaissance Technologies LLC	1,643,747	$3.50M	0.0%	+73.1%	2.869%
5/14/2026	Arrowstreet Capital Limited Partnership	834,570	$1.78M	0.0%	-19.8%	1.456%
5/14/2026	Sei Investments Co.	39,683	$85K	0.0%	N/A	0.069%
5/7/2026	Dimensional Fund Advisors LP	1,301,664	$2.77M	0.0%	+51.9%	2.272%
5/5/2026	Bank of New York Mellon Corp	189,148	$403K	0.0%	-11.9%	0.330%
4/28/2026	Kathmere Capital Management LLC	13,813	$29K	0.0%	-56.6%	0.024%
4/20/2026	Ritholtz Wealth Management	165,333	$352K	0.0%	-27.4%	0.289%
4/17/2026	Brookstone Capital Management	14,290	$30K	0.0%	N/A	0.025%
2/19/2026	T. Rowe Price Investment Management Inc.	10,606,599	$25.78M	0.0%	-1.3%	18.618%
2/19/2026	Invesco Ltd.	131,438	$319K	0.0%	+37.9%	0.231%
2/18/2026	Mackenzie Financial Corp	352,454	$876K	0.0%	N/A	0.619%
2/18/2026	XTX Topco Ltd	119,679	$291K	0.0%	-44.6%	0.210%
2/18/2026	nVerses Capital LLC	10,722	$26K	0.1%	N/A	0.019%
2/18/2026	Stokes Family Office LLC	11,077	$27K	0.0%	N/A	0.019%
2/18/2026	Verdad Advisers LP	96,286	$234K	0.1%	N/A	0.169%
2/18/2026	Vestal Point Capital LP	870,000	$2.11M	0.1%	-84.3%	1.527%
2/18/2026	Susquehanna Portfolio Strategies LLC	158,984	$386K	0.0%	-24.7%	0.279%
2/18/2026	Oxford Asset Management LLP	114,383	$278K	0.1%	N/A	0.201%
2/18/2026	Millennium Management LLC	296,556	$721K	0.0%	-65.1%	0.521%
2/18/2026	Man Group plc	130,033	$316K	0.0%	+66.0%	0.228%
2/18/2026	Engineers Gate Manager LP	19,701	$48K	0.0%	+48.9%	0.035%
2/18/2026	Bridgeway Capital Management LLC	173,300	$421K	0.0%	+76.3%	0.304%
2/18/2026	683 Capital Management LLC	247,958	$603K	0.0%	N/A	0.435%
2/17/2026	J. Goldman & Co LP	270,000	$656K	0.0%	N/A	0.474%
The end may be near for these iconic stocks (Ad) Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are triggering a historic wealth transfer already underway in 2026. Household names like Intuit (-57%), Boston Scientific (-49%), and Tractor Supply (-40%) are cratering, while lesser-known companies like Sandisk (+573%) and Rackspace (+444%) surge. Chaikin has identified specific stocks he believes investors should sell before they fall further - and the names may surprise you. He's also pinpointing a company tapped as Nvidia's self-driving partner and a potential AI megadeal that could split into three high-growth stocks. Stream his free presentation to get every buy and sell recommendation with no membership or credit card required. Watch Marc Chaikin's free presentation and get his full buy-and-sell list today
2/17/2026	Jump Financial LLC	39,026	$95K	0.0%	N/A	0.069%
2/17/2026	T. Rowe Price Investment Management Inc.	2,332,222	$5.67M	0.0%	-78.3%	4.094%
2/17/2026	Graham Capital Management L.P.	86,556	$210K	0.0%	+137.0%	0.152%
2/16/2026	OMERS ADMINISTRATION Corp	138,900	$338K	0.0%	+1,162.7%	0.244%
2/16/2026	Barclays PLC	74,810	$182K	0.0%	+227.1%	0.131%
2/13/2026	Marshall Wace LLP	1,110,088	$2.70M	0.0%	-14.6%	1.949%
2/13/2026	Stifel Financial Corp	274,995	$668K	0.0%	+23.7%	0.483%
2/13/2026	AWM Investment Company Inc.	625,000	$1.52M	0.1%	+4.2%	1.097%
2/12/2026	HRT Financial LP	26,351	$64K	0.0%	N/A	0.046%
2/12/2026	Renaissance Technologies LLC	949,735	$2.31M	0.0%	+58.4%	1.667%
2/12/2026	Dimensional Fund Advisors LP	857,015	$2.08M	0.0%	+88.0%	1.504%
2/12/2026	AlphaCentric Advisors LLC	53,625	$130K	0.1%	N/A	0.094%
2/11/2026	LPL Financial LLC	36,990	$90K	0.0%	-46.6%	0.065%
2/11/2026	O Shaughnessy Asset Management LLC	354,454	$861K	0.0%	+148.8%	0.622%
2/11/2026	WINTON GROUP Ltd	421,280	$1.02M	0.0%	N/A	0.739%
2/11/2026	State of Wyoming	70,343	$171K	0.0%	+189.6%	0.123%
2/10/2026	TD Asset Management Inc	195,930	$476K	0.0%	+6.8%	0.344%
2/10/2026	Goldman Sachs Group Inc.	325,327	$791K	0.0%	-27.5%	0.571%
2/9/2026	Geode Capital Management LLC	505,780	$1.23M	0.0%	+1.1%	0.888%
2/3/2026	RB Capital Management LLC	35,000	$85K	0.0%	N/A	0.061%
1/27/2026	Round Rock Advisors LLC	79,539	$193K	0.0%	N/A	0.140%
1/27/2026	HCR Wealth Advisors	27,000	$66K	0.0%	N/A	0.047%
1/23/2026	Ritholtz Wealth Management	227,870	$554K	0.0%	+124.5%	0.400%
1/13/2026	Kathmere Capital Management LLC	31,822	$77K	0.0%	+31.0%	0.056%
11/17/2025	XTX Topco Ltd	216,195	$819K	0.0%	+20.6%	0.379%
11/17/2025	Vestal Point Capital LP	5,550,000	$21.03M	0.9%	-0.9%	9.742%
11/17/2025	Qube Research & Technologies Ltd	78,266	$297K	0.0%	+17.8%	0.137%
11/17/2025	Millennium Management LLC	850,331	$3.22M	0.0%	-10.0%	1.493%
11/17/2025	Bank of America Corp DE	43,359	$164K	0.0%	+22.5%	0.076%
11/14/2025	Raymond James Financial Inc.	17,215	$65K	0.0%	-53.3%	0.030%
11/14/2025	Virtu Financial LLC	10,415	$39K	0.0%	N/A	0.018%
11/14/2025	Man Group plc	78,326	$297K	0.0%	+88.4%	0.137%
11/14/2025	Squarepoint Ops LLC	17,181	$65K	0.0%	-79.4%	0.030%
11/13/2025	Kennedy Capital Management LLC	129,944	$492K	0.0%	+97.3%	0.228%
11/13/2025	Arrowstreet Capital Limited Partnership	896,853	$3.40M	0.0%	+549.2%	1.574%
11/13/2025	UBS Group AG	628,416	$2.38M	0.0%	+100.3%	1.103%
11/13/2025	Jefferies Financial Group Inc.	22,800	$86K	0.0%	N/A	0.040%
11/10/2025	TD Asset Management Inc	183,420	$695K	0.0%	+10.7%	0.322%
11/10/2025	Hillsdale Investment Management Inc.	63,623	$241K	0.0%	N/A	0.112%
11/7/2025	GSA Capital Partners LLP	122,758	$465K	0.0%	-48.9%	0.216%
11/7/2025	Vanguard Group Inc.	2,188,857	$8.30M	0.0%	+4.1%	3.844%
11/4/2025	Brown Wealth Management LLC	20,932	$79K	0.0%	-79.1%	0.037%
11/4/2025	State of Wyoming	24,292	$92K	0.0%	N/A	0.043%
10/28/2025	Ritholtz Wealth Management	101,479	$385K	0.0%	N/A	0.178%
10/22/2025	Kathmere Capital Management LLC	24,283	$92K	0.0%	N/A	0.043%
10/17/2025	Ethic Inc.	15,592	$59K	0.0%	N/A	0.027%
8/18/2025	Hudson Bay Capital Management LP	10,440	$26K	0.0%	N/A	0.018%
8/15/2025	Tower Research Capital LLC TRC	21,031	$52K	0.0%	+217.6%	0.037%
8/15/2025	Man Group plc	41,577	$103K	0.0%	N/A	0.073%
8/15/2025	Hudson Bay Capital Management LP	10,440	$26K	0.0%	N/A	0.018%
The REAL Reason Trump is Invading Iran (Ad) For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason. Click here to find out what it is.
8/15/2025	Engineers Gate Manager LP	32,884	$82K	0.0%	N/A	0.058%
8/15/2025	Bridgeway Capital Management LLC	98,300	$244K	0.0%	+34.5%	0.173%
8/15/2025	Bank of America Corp DE	35,387	$88K	0.0%	-23.2%	0.062%
8/14/2025	Jane Street Group LLC	208,477	$517K	0.0%	N/A	0.366%
8/14/2025	Qube Research & Technologies Ltd	66,451	$165K	0.0%	+158.1%	0.117%
8/14/2025	Cerity Partners LLC	10,299	$26K	0.0%	N/A	0.018%
8/13/2025	Jump Financial LLC	13,065	$32K	0.0%	N/A	0.023%
8/13/2025	Marshall Wace LLP	737,875	$1.83M	0.0%	N/A	1.296%
8/13/2025	Invesco Ltd.	60,210	$149K	0.0%	+30.9%	0.106%
8/13/2025	Arrowstreet Capital Limited Partnership	138,144	$343K	0.0%	N/A	0.243%

BDTX Institutional Ownership - Frequently Asked Questions

During the previous two years, 105 institutional investors and hedge funds held shares of Black Diamond Therapeutics. The most heavily invested institutionals were T. Rowe Price Investment Management Inc. ($25.78M), Vanguard Group Inc. ($8.30M), BlackRock Inc. ($7.25M), Tang Capital Management LLC ($4.43M), State Street Corp ($3.52M), Renaissance Technologies LLC ($3.50M), and Point72 Asset Management L.P. ($3.03M).Learn more on Black Diamond Therapeutics' institutional investors.

95.47% of Black Diamond Therapeutics' stock is owned by institutional investors. Learn more on BDTX's institutional investor holdings.

Of the 97 institutional investors that purchased Black Diamond Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BlackRock Inc. ($3.92M), Vestal Point Capital LP ($3.50M), Renaissance Technologies LLC ($1.69M), AWM Investment Company Inc. ($1.53M), Dimensional Fund Advisors LP ($1.25M), Connor Clark & Lunn Investment Management Ltd. ($1.09M), and Arrowstreet Capital Limited Partnership ($896.85K).

Institutional investors have bought a total of 14,035,586 shares in the last 24 months. This purchase volume represents approximately $31.47M in transactions.

Of the 17 institutional investors that sold Black Diamond Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: T. Rowe Price Investment Management Inc. ($8.55M), Vestal Point Capital LP ($4.73M), Millennium Management LLC ($648.30K), Arrowstreet Capital Limited Partnership ($205.90K), Marshall Wace LLP ($189.12K), Goldman Sachs Group Inc. ($123.69K), and GSA Capital Partners LLP ($117.25K).

Institutional investors have sold a total of 15,091,721 shares in the last 24 months. This volume of shares sold represents approximately $37.14M in transactions.

Related Companies

Institutional ownership data for NASDAQ:BDTX is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 9/8/2026. New 13F filings are added each quarter as they're published.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Black Diamond Therapeutics (BDTX) Institutional Ownership

BDTX Institutional Buying and Selling by Quarter

Black Diamond Therapeutics Major Shareholders & Ownership History

BDTX Institutional Ownership - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Black Diamond Therapeutics (BDTX) Institutional Ownership

Institutional Ownership Changes (13F Filings) for Black Diamond Therapeutics (NASDAQ:BDTX)

BDTX Institutional Buying and Selling by Quarter

Black Diamond Therapeutics Major Shareholders & Ownership History

BDTX Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of BDTX shares?

What percentage of Black Diamond Therapeutics' stock is owned by institutional investors?

Which institutional investors have been buying Black Diamond Therapeutics' stock?

How much institutional buying is happening at Black Diamond Therapeutics?

Which of Black Diamond Therapeutics' major shareholders have been selling company stock?

How much institutional selling is happening at Black Diamond Therapeutics?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools